Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AMG 655 with Paclitaxel and Carboplatin in Advanced NSCLC
NCT00534027Phase 2Completed
- Sponsor
- Amgen
- Start
- Jan 2008
- Primary completion
- Mar 2011
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
01
Overview
A Phase 2 trial of conatumumab in non-small cell lung cancer (NSCLC), sponsored by Amgen. Started Jan 2008; status: completed.
02
Drugs
conatumumab
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00534027.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00534027.